Europeanguidelinesonperioperativevenousthromboembolismprophylaxis
Chronictreatmentswithantiplateletagents
欧洲围手术期静脉血栓预防指南:抗血小板药物的慢性病治疗
Antiplateletagents(APA)areconsideredfirst-linetherapyinpreventingcardiovascularthromboticevents,buttheyareoflimitedvalueintheprophylaxisofvenousthromboembolism(VTE)duringtheperioperativeperiod.Consequently,manypatientsshouldreceivebothanAPAandananticoagulant.
抗血小板药物(APA)是目前公认的心血管栓塞一线治疗药物,但是在围手术期静脉血栓栓塞(VTE)预防中价值有限。因此,许多患者同时接受APA和抗凝药物治疗。
This